Decision Diagnostics Cost of Goods Sold 2010-2011 | DECN

Decision Diagnostics cost of goods sold from 2010 to 2011. Cost of goods sold can be defined as the difference between beginning and ending inventories for tangible products resulting in an expense that reflects production and sales costs.
Decision Diagnostics Annual Cost of Goods Sold
(Millions of US $)
2010 $17
2009 $18
Decision Diagnostics Quarterly Cost of Goods Sold
(Millions of US $)
2011-09-30 $3
2011-06-30 $3
2011-03-31 $3
2010-12-31 $5
2010-09-30 $4
2010-06-30 $5
2010-03-31 $4
2009-12-31 $4
2009-09-30 $4
2009-06-30 $5
2009-03-31 $5
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.000B $0.000B
Decision Diagnostics Corp. is engaged in developing products that offer solutions in medical care and management by providing physicians with information at the point of care. The Company uses smart phones which allow physicians to carry, access and update their patients' histories, medication data, and best care guidelines at the point of care. Decision Diagnostics Corp. is a leading provider of prescription drugs, home testing products for the chronically ill, a leading fulfillment provider of direct to patient diabetes programs, and a leading developer of revolutionary cell phone centric e-health products and technologies. Decision Diagnostics Corp., formerly known as Instacare Corp., is based in Westlake Village, California.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $39.281B 54.26
Hims & Hers Health (HIMS) United States $12.358B 128.40
Tempus AI (TEM) United States $10.796B 0.00
Inspire Medical Systems (INSP) United States $4.614B 72.09
IRhythm Technologies (IRTC) United States $4.399B 0.00
Privia Health (PRVA) United States $3.055B 208.83
Enovis (ENOV) United States $2.089B 11.65
Clover Health Investments (CLOV) United States $1.773B 0.00
Schrodinger (SDGR) United States $1.765B 0.00
Phreesia (PHR) United States $1.531B 0.00
Azenta (AZTA) United States $1.296B 60.21
Omnicell (OMCL) United States $1.286B 22.69
10x Genomics (TXG) United States $1.161B 0.00
Fulgent Genetics (FLGT) United States $0.613B 0.00
Butterfly Network (BFLY) United States $0.581B 0.00
Talkspace (TALK) United States $0.515B 154.00
Veradigm (MDRX) United States $0.455B 0.00
Standard BioTools (LAB) United States $0.441B 0.00
TruBridge (TBRG) United States $0.395B 875.67
Claritev (CTEV) United States $0.353B 0.00
Health Catalyst (HCAT) United States $0.315B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.212B 0.00
Nyxoah SA (NYXH) Belgium $0.204B 0.00
EUDA Health Holdings (EUDA) Singapore $0.151B 0.00
Pulmonx (LUNG) United States $0.148B 0.00
American Well (AMWL) United States $0.113B 0.00
MDxHealth SA (MDXH) Belgium $0.087B 0.00
CareCloud (CCLD) United States $0.086B 3.27
Retrieve Medical Holdings (RMHI) United States $0.083B 0.00
111 (YI) China $0.068B 0.00
P3 Health Partners (PIII) United States $0.061B 0.00
Outset Medical (OM) United States $0.059B 0.00
HeartBeam (BEAT) United States $0.058B 0.00
Zepp Health (ZEPP) Netherlands $0.043B 0.00
Zhongchao (ZCMD) China $0.029B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.021B 0.00
Bullfrog AI Holdings (BFRG) United States $0.017B 0.00
MSP Recovery (MSPR) United States $0.016B 0.00
Streamline Health Solutions (STRM) United States $0.011B 0.00
Strata Skin Sciences (SSKN) United States $0.011B 0.00
Healthcare Triangle (HCTI) United States $0.010B 0.00
Predictive Oncology (POAI) United States $0.010B 0.00
Precipio (PRPO) United States $0.010B 0.00
Movano (MOVE) United States $0.006B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00